A vaccine for schistosomiasis: Alternative approaches

Parasitology Today

Volumn 14, Issue 3, 1998, Pages 105-109

  Doenhoff, Micahel J ^a  

^a BANGOR UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PARASITE ANTIGEN; SCHISTOSOMA VACCINE; SERINE PROTEINASE;

ARTICLE; IMMUNITY; IMMUNOGENICITY; MOLECULAR WEIGHT; WORLD HEALTH ORGANIZATION;

EID: 0032031481     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(97)01204-0     Document Type: Article

References (48)

1. 1 Bergquist, N.R. (1995) Controlling schistosomiasis by vaccination: a realistic option? Parasitol. Today 11, 191-194
2. 2 Taylor, R.B. et al. (1988) The glutathione transferase activity and tissue distribution of a cloned Mr 28K protective antigen of Schistosoma mansoni. Mol. Biochem. Parasitol. 41, 35-44
3. 3 Pearce, E.J. et al. (1986) Immunological characterization and purification of Sm97, a Schistosoma mansoni antigen mono-specifically recognized by antibodies from mice protectively immunized with a non-living vaccine. J. Immunol. 137, 3593-3600
4. 4 Amory-Soisson, L.M. et al. (1999) Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. Immunol. 149, 3612-3620
5. 5 Shoemaker, C. et al. (1992) cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose phosphate isomerase. Proc. Natl. Acad. Sci. U. S. A. 89, 1842-1846
6. 6 Reynolds, S.R. et al. (1992) T and B cell epitope mapping of Sm23, an integral membrane protein of Schistosoma mansoni. J. Immunol. 149, 3995-4001
7. 7 Tendler, E.M. et al. (1946) A Schistosoma mansoni fatty-acid-binding protein, Sm14, is the potential basis of a dual purpose anti-helminth vaccine. Proc. Natl. Acad. Sci. U. S. A. 93, 269-273
8. 8 Newport, G.R. and Colley, D.G. (1993) in Immunology and Molecular Biology of Parasitic Infections, 3rd edn (Warren, K.S., ed.), pp 387-437, Blackwell Scientific Publishers
9. 9 Pierce, R.J. and Capron, A.R. (1994) in Modern Vaccinoloogy (Kurstak, E., ed.), pp 357-380, Plenum Medical
10. 10 Waine, G.J. and McManus, D.P. (1997) Schistosomiasis vaccine development - the current picture. BioEssays 19, 435-443
11. 11 Goudot-Crozel, V. et al. (1989) The major surface parasite antigen associated with human resistance to schistosomiasis is a 37 kDa glyceraldehyde-3-phosphate dehydrogenase. J. Exp. Med. 170, 2065-2080
12. 12 Webster, M. et al. (1996) Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low infection intensities after treatment. Infect. Immun. 64, 4042-4046
13. 13 Grzych, J.M. et al. (1985) An anti-idiotype vaccine against experimental schistosomiasis. Nature 316, 74-76
14. 14 Sher, A. (1988) in The Biology of Parasitism (Englund, P.T. and Sher, A., eds), pp 169-182, Alan R. Liss
15. 15 Darani, H.Y. et al. (1997) Schistosoma mansoni: anomalous immunogenic properties of a 27 kDa larval serine protease associated with protective immunity. Parasitology 115, 237-247
16. 16 Marikovsky, M. et al. (1988) Purification and characterization of an elastinolytic proteinase secreted by cercariae of S. mansoni. Mol. Biochem. Parasitol. 30, 45-54
17. 17 Newport, G.R. et al. (1988) Cloning of the protease that facilitates infection by schistosome parasites. J. Biol. Chem. 263, 13179-13184
18. 18 McKerrow, J.H. et al. (1991) Recent insights into the structure and function of a larval proteinase involved in host infection by a multicellular parasite. Proc. Soc. Exp. Biol. Med. 197, 119-124
19. 19 Benacerraf, B. and McDevitt, H.O. (1972) Histocompatibility-linked immune response genes. Science 175, 273-276
20. 20 Modha, J. and Doenhoff, M.J. (1994) Complex formation of human alpha-1-antitrypsin with components in Schistosoma mansoni cercariae. Parasite Immunol. 16, 447-450
21. 21 Modha, J., Roberts, M.C. and Kusel, J. (1996) Schistosomes and serpins: a complex business. Parasitol. Today 12, 119-121
22. 22 Price, H.P. et al. (1997) Cloning, heterologous expression and antigenicity of a schistosome cercarial protease. Parasitology 114, 447-453
23. 23 McKerrow, J.H. et al. (1985) Proteinases from invasive larvae of the trematode parasite Schistosoma mansoni degrade connective tissue and basement membrane macromolecules. Biochem. J. 231, 47-51
24. 24 Texeira, M. et al. (1993) Mechanisms of inflammatory response induced by extracts of Schistosoma mansoni larvae in guinea pig skin. J. Immunol. 151, 5525-5534
25. 25 Fallon, P.G. et al. (1996) Enhancement of Schistosoma mansoni infectivity by intradermal injection of larval extracts: a putative role for larval proteases. J. Infect. Dis. 173, 1460-1466
26. 26 Ghendler, Y. et al. (1996) Schistosoma mansoni: evidence for a 28 kDa membrane-anchored protease on schistosomula. Exp. Parasitol. 83, 73-82
27. 27 Sayers, J.R. et al. (1995) AGA/AGG codon usage in parasites: implications for gene expression in Escherichia coli. Parasitol. Today 11, 345-346
28. 28 Curtis, R.H.C. et al. (1996) Sm480: a high molecular weight Schistosoma mansoni antigen associated with protective immunity. Parasite Immunol. 18, 149-157
29. 29 Butterworth, A.E. et al. (1988) Immunity in human schistosomiasis: cross-reactive IgM and IgG2 antibodies block the expression of immunity. Biochimic 70, 1053-1063
30. 30 Khalife, J. et al. (1986) Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies. J. Exp. Med. 142, 4422-4427
31. 31 Yi, X.Y. et al. (1986) IgM antibodies recognizing carbohydrate epitopes shared between schistosomula and miracidia of Schistosoma mansoni that block in vitro killing. J. Immunol. 137, 3946-3954
32. 32 Dunne, D.W. et al. (1981) Identification and partial purification of an antigen (ω1) from Schistosoma mansoni eggs which is putatively hepatotoxic in T-cell deprived mice. Trans. R. Soc. Trop. Med. Hyg. 75, 54-71
33. 33 Coulson, P.S. (1997) The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine. Adv. Parasitol. 39, 272-323
34. 34 Taylor, M.G. and Bickle, Q.D. (1986) Irradiated schistosome vaccines. Parasitol. Today 2, 132-134
35. 35 Munn, E.A. (1997) Rational design of nematode vaccines: hidden antigens. Int. J. Parasitol. 27, 359-366
36. 36 Willadsen, P. et al. (1995) Cmmercialization of a recombinant vaccine against Boophilus microplus. Parasitology 110, S43-S50
37. 37 Harn, D.A. et al. (1992) A protective monoclonal antibody specifically recognizes and alters the catalytic activity of schistosome triose-phosphate isomerase. J Immunol. 148, 562-567
38. 38 Wilson, R.A. and Sher, A. (1993) Vaccines against schistosomiasis: an alternative view. Trans. R. Soc. Trop. Med. Hyg. 87, 237
39. 39 Jankovic, D. et al. (1996) Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni. J. Immunol. 157, 806-814
40. 40 Lehner, P.J. and Cresswell, P. (1996) Processing and delivery of peptides presented by MHC class 1 molecules. Curr. Opin. Immunol. 8, 59-67
41. 41 Ferru, I. et al. (1997) Analysis of the immune response elicited by a multiple antigen peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni. Parasite Immunol. 19, 1-11
42. 42 Mountford, A.P. et al. (1996) Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J. Immunol. 156, 4739-4745
43. 4 Wynnn, T.A. et al. (1996) IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J. Immunol. 157, 4068-4078
44. 44 Maurice I. (1995) Gene vaccines. Mol. Med. Today 1, 64-71
45. 45 Waine, G.J. et al. (1997) DNA based vaccination using Schistosoma japonicum (Asian blood fluke) genes. Vaccine 15, 846-848
46. 46 Dunne, D.W. et al. (1995) Prospects for immunological control of schistosomiasis. Lancet 345, 1488-1492
47. 47 Dunne, D.W. et al. (1986) Schistosoma mansoni egg antigens: preparation of rabbit antisera with monospecific precipitating activity, and their use in antigen characterization. Parasite Immunol. 8, 575-586
48. 48 Wiesner, J. et al. (1998) Biology of giant proteins of Plasmodium: Resolution on polyacrylamide-agarose composite gels. Parasitol. Today 14, 38-40